Sign in

NCT05482126Suspended

Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 24 Sept 2026

Brief summary (registry, in English)

The investigators are investigating the brain activity associated with sensory information in movement disorders in order to improve treatment of these symptoms beyond what is currently available.

Status (registry)
Suspended
Study type
Observational
Enrollment
30 (estimated)
First submitted
26 Jul 2022
Start date
8 Jun 2022
Primary completion date
1 Aug 2026
Lead sponsor
University of Alabama at Birmingham
NCT number
NCT05482126

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior DBS surgery or ablation
  • Unable to withhold dopaminergic medications for at least 12 hours prior to scheduled visit
  • Previous diagnosis of PD, other movement disorder, or other significant neurological disease.

Other illness

  • Medical contraindications such as current uncontrolled hypertension, heart disease, coagulopathy, or other conditions that might increase the risk of surgery
  • Diagnosis or suspicion of atypical Parkinsonism (PSP, MSA, CBD) or drug-induced Parkinsonism, or significant neurological disease other than PD.
  • Diagnosis of psychogenic movement disorder based on consensus criteria

Age

  • Age \<18 years.
  • Clinical dementia and/or Dementia Rating Scale (DRS) score of \<5th percentile adjusted for age and education level, based upon routine pre-op NP testing.
  • Age \<18 years.

Who the study is looking for

  • Age \>18 years
  • Clinically definite, advanced idiopathic PD based on consensus criteria.
  • Normal, or essentially normal, preoperative brain MRI.
  • Patient is available for follow-up visits over the length of the study
  • Patient has elected to undergo DBS surgery as part of routine care, and subthalamic nucleus (STN) is determined as the appropriate surgical target
  • Age \>18 years.
  • No diagnosis of PD, other movement disorder, or other significant neurological disease.

Age in the registry: 18 years to 89 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
The University of Alabama at Birmingham Hospital
Coordinator of this site? Confirm its status
BirminghamUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.